Ionis Pharmaceuticals, Inc. (IONS)
79.74
-1.08
(-1.34%)
USD |
NASDAQ |
Dec 15, 16:00
82.95
+3.21
(+4.03%)
After-Hours: 20:00
Ionis Pharmaceuticals Research and Development Expense (Annual): 901.53M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biogen, Inc. | 1.755B |
| Merck & Co., Inc. | 15.79B |
| Pfizer Inc. | 10.74B |
| Eli Lilly & Co. | 10.99B |
| Cogent Biosciences, Inc. | 228.26M |